Pierre-Alexandre Just

No ORCID on file · 10 papers in corpus · active 2016-2025

Study types

  • article 8
  • review 2

Condition tags

  • endometriosis 6
  • infertility 2
  • die_deep_infiltrating 2
  • chronic_pelvic_pain 1
  • adenomyosis 1
article 2025
·doi:10.13140/rg.2.2.35366.18248/1
article 2025
·doi:10.13140/rg.2.2.35366.18248/3
article 2025
·doi:10.13140/rg.2.2.35366.18248/2
article 2025
·doi:10.13140/rg.2.2.35366.18248
review 2025
Diagnostics ·doi:10.3390/diagnostics15121508

Objectives: Endometriosis is a common gynecologic condition characterized by the presence of endometrial-like tissue outside the uterus, often leading to pelvic pain and infertility. Diagnosis is frequently delayed, with prolonged diagnosti…

article 2024
The British journal of radiology ·doi:10.1093/bjr/tqae072

OBJECTIVE: This study aimed to establish the first-ever MRI classification of uterosacral ligament (USL) involvement in deep infiltrating endometriosis (DIE), based on reliable preoperative MRI features correlated with positive predictive v…

article 2022
Biomedicines ·doi:10.3390/biomedicines10092065

Objective: To identify circulating miRNAs associated with ovarian endometriosis (OMA), and to analyze candidate genes targeted by these miRNAs. Methods: Putative regulating miRNAs were identified through an original bioinformatics approach.…

article 2021
Annales de pathologie ·doi:10.1016/j.annpat.2021.03.012

Diffuse adenomyosis, focal adenomyosis, ovarian endometrioma, superficial endometriosis and deep infiltrating adenomyosis are all defined by the presence of an endometrioid tissue in an ectopic location that is at distance from the endometr…

review 2020
Human reproduction update ·doi:10.1093/humupd/dmz049

BACKGROUND: Adenomyosis is a benign uterine disorder where endometrial glands and stroma are pathologically demonstrated within the uterine myometrium. The pathogenesis involves sex steroid hormone abnormalities, inflammation, fibrosis and …

article 2016
Expert opinion on therapeutic targets ·doi:10.1080/14728222.2016.1180367

OBJECTIVE: Mitogen-activated protein kinases (MAPKs) are involved in the proliferation and survival of endometriotic lesions. Vemurafenib (PLX4032) is a novel protein kinase inhibitor that targets BRAF, a member of the MAPK pathway. The pre…